Alzamend Neuro, Inc. (ALZN) Social Stream



Alzamend Neuro, Inc. (ALZN): $1.39

0.08 (-5.14%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add ALZN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#166 of 333

in industry

ALZAMEND NEURO INC (ALZN) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ALZN.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-01 1 $8 $8 $8 $0.98 716.33%
2022-09-30 2 $15 $8 $11.5 $0.98 1073.47%
2023-04-21 1 $1.5 $1.5 $1.5 $0.98 53.06%
2023-10-13 1 $14.992 $14.992 $14.992 $0.98 1429.8%
2023-11-10 1 $15 $15 $15 $0.98 1430.61%

Price Target Last Issued October 13, 2023

The Trend in the Analyst Price Target


Over the past 30 weeks, ALZN's average price target has gone up $13.5.

Over the past 30 weeks, ALZN's average upside potential has been 1,760.73%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-12 1 1.500 1.500 1.500 0.570 163.16%
2023-04-21 1 1.500 1.500 1.500 0.600 150%
2023-10-13 1 14.992 14.992 14.992 0.206 7177.67%
2023-10-13 1 1.000 1.000 1.000 0.206 385.44%
2023-11-10 1 15.000 15.000 15.000 1.460 927.4%

ALZN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


ALZN's average broker recommendation rating improved by 1 over the prior 25 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • ALZN has a higher number of analysts covering the stock than 5.66% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, ALZAMEND NEURO INC's variance in analysts' estimates is lower than 29.47% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, ALZAMEND NEURO INC's upside potential (average analyst target price relative to current price) is greater than 514.37% of them.
  • ALZN has a higher average analyst price target than 101.52% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ALZAMEND NEURO INC are CYT, GHRS, and AVTE.

What is the outlook for ALZN? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!